NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer.
Lécuyer L, Victor Bala A, Deschasaux M, Bouchemal N, Nawfal Triba M, Vasson MP, Rossary A, Demidem A, Galan P, Hercberg S, Partula V, Le Moyec L, Srour B, Fiolet T, Latino-Martel P, Kesse-Guyot E, Savarin P, Touvier M.
Lécuyer L, et al. Among authors: srour b.
Int J Epidemiol. 2018 Apr 1;47(2):484-494. doi: 10.1093/ije/dyx271.
Int J Epidemiol. 2018.
PMID: 29365091